TDOC Valuation

Teladoc Health Inc

Add to Watchlist

Advanced Chart

6.990

-0.08(-1.132%)1D

TDOC Relative Valuation

TDOC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, TDOC is overvalued; if below, it's undervalued.

Historical Valuation

Teladoc Health Inc (TDOC) is now in the Fair zone, suggesting that its current forward PS ratio of 7.47 is considered Fairly compared with the five-year average of -35.96. The fair price of Teladoc Health Inc (TDOC) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：6.99

Fair

-8.14

Trailing

Forward

5.62

EV/EBITDA

Teladoc Health Inc. (TDOC) has a current EV/EBITDA of 5.62. The 5-year average EV/EBITDA is 32.81. The thresholds are as follows: Strongly Undervalued below -42.70, Undervalued between -42.70 and -4.94, Fairly Valued between 70.57 and -4.94, Overvalued between 70.57 and 108.32, and Strongly Overvalued above 108.32. The current Forward EV/EBITDA of 5.62 falls within the Historic Trend Line -Fairly Valued range.

-10.25

EV/EBIT

Teladoc Health Inc. (TDOC) has a current EV/EBIT of -10.25. The 5-year average EV/EBIT is -84.68. The thresholds are as follows: Strongly Undervalued below -748.81, Undervalued between -748.81 and -416.75, Fairly Valued between 247.38 and -416.75, Overvalued between 247.38 and 579.45, and Strongly Overvalued above 579.45. The current Forward EV/EBIT of -10.25 falls within the Historic Trend Line -Fairly Valued range.

7.47

Teladoc Health Inc. (TDOC) has a current PS of 7.47. The 5-year average PS is 3.96. The thresholds are as follows: Strongly Undervalued below -5.84, Undervalued between -5.84 and -0.94, Fairly Valued between 8.86 and -0.94, Overvalued between 8.86 and 13.76, and Strongly Overvalued above 13.76. The current Forward PS of 7.47 falls within the Historic Trend Line -Fairly Valued range.

4.27

P/OCF

Teladoc Health Inc. (TDOC) has a current P/OCF of 4.27. The 5-year average P/OCF is 42.71. The thresholds are as follows: Strongly Undervalued below -74.56, Undervalued between -74.56 and -15.93, Fairly Valued between 101.35 and -15.93, Overvalued between 101.35 and 159.98, and Strongly Overvalued above 159.98. The current Forward P/OCF of 4.27 falls within the Historic Trend Line -Fairly Valued range.

6.24

P/FCF

Teladoc Health Inc. (TDOC) has a current P/FCF of 6.24. The 5-year average P/FCF is 66.88. The thresholds are as follows: Strongly Undervalued below -121.75, Undervalued between -121.75 and -27.44, Fairly Valued between 161.19 and -27.44, Overvalued between 161.19 and 255.51, and Strongly Overvalued above 255.51. The current Forward P/FCF of 6.24 falls within the Historic Trend Line -Fairly Valued range.

Teladoc Health Inc (TDOC) has a current Price-to-Book (P/B) ratio of 0.95. Compared to its 3-year average P/B ratio of 1.24 , the current P/B ratio is approximately -23.15% higher. Relative to its 5-year average P/B ratio of 1.39, the current P/B ratio is about -31.62% higher. Teladoc Health Inc (TDOC) has a Forward Free Cash Flow (FCF) yield of approximately 21.13%. Compared to its 3-year average FCF yield of 14.02%, the current FCF yield is approximately 50.73% lower. Relative to its 5-year average FCF yield of 8.86% , the current FCF yield is about 138.54% lower.

0.95

P/B

Median3y

1.24

Median5y

1.39

21.13

FCF Yield

Median3y

14.02

Median5y

8.86

Competitors Valuation Multiple

The average P/S ratio for TDOC's competitors is 24.41, providing a benchmark for relative valuation. Teladoc Health Inc Corp (TDOC) exhibits a P/S ratio of 7.47, which is -69.40% above the industry average. Given its robust revenue growth of -2.20%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

US Physical Therapy Inc

Performance Decomposition

Market capitalization of TDOC decreased by 40.98% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -5.20 to -7.90.

The secondary factor is the Revenue Growth, contributed -2.20%to the performance.

Overall, the performance of TDOC in the past 1 year is driven by Margin Expansion. Which is more sustainable.

-2.20%

640.51M → 626.44M

Revenue Growth

51.92%

-5.20 → -7.90

Margin Expansion

-90.70%

-62.85 → -5.85

P/E Change

-40.98%